Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Parkinson's Disease (PD) Clinical Trials

6 recruiting trials for Parkinson's Disease (PD). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
1
Phase 3 Trials
6
Sponsors

Recruiting Trials

RECRUITINGNCT07488026

Effects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's Disease

This randomized clinical trial aims to compare the effects of two different trans-spinal magnetic stimulation (tsMS) application sites, cervical versus thoracic, when combined...

Sponsor: Universidade Federal de PernambucoEnrolling: 301 location
RECRUITINGEarly Phase 1NCT07348250

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

This clinical study is being conducted to learn more about a new imaging drug called \[18F\]MK-0947, which is designed to help doctors see changes in the brain related to...

Sponsor: InvicroEnrolling: 221 location
RECRUITINGPhase 1NCT07310264

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

This is a first-in-human (FIH) study of orally administered VT-5006 (also known as AX-5006) in healthy adult volunteers (HVs) and adult participants with Parkinson's disease (PD)....

Sponsor: Vertero TherapeuticsEnrolling: 841 location
RECRUITINGNCT05916157

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In...

Parkinson's disease (PD) is a neurological condition, which affects the brain. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is...

Sponsor: AbbVieEnrolling: 25016 locations
RECRUITINGPhase 3NCT07316296

Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a...

The goal of this clinical trial is to learn if the medication atomoxetine can reduce freezing of gait in people with Parkinson's disease. The main questions it aims to answer is:...

Sponsor: Radboud University Medical CenterEnrolling: 601 location
RECRUITINGNCT07380204

Quantification of Hsp90 in the Human Brain

This study tests the radiolabeled molecule ("tracer"), \[¹¹C\]HSP990, using positron emission tomography (PET) imaging to assess whether it can be used to measure levels of Heat...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 481 location